Drug may boost vaccine responses in older adults
A preliminary study from Professor Katja Simon’s research group at the Kennedy Institute shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults. Read more here....
3D imaging reveals the role of blood vessels in hormone production
Research from Kennedy Trust Senior Research Fellow Anjali Kusumbe’s group at the Kennedy Institute has shown a direct correlation between age-related decline in capillary and artery numbers and hormone production in the endocrine system. Read more here....
The Kennedy Trust launches its MB PhD scheme
Mindful of the importance of clinician scientists and the key role they play in translating discovery into clinical use, the Trust is delighted to announce the launch of its MB PhD scheme. The programme supports aspiring clinician scientists to undertake...
New breakthrough in the treatment of rheumatoid arthritis
A trial led by Professor Chris Buckley, Kennedy Professor of Translational Rheumatology at the Universities of Oxford and Birmingham, has explored the effectiveness of otilimab in the treatment of rheumatoid arthritis. Read more here....
Understanding the physics of the immune response necessitates new technology
Professor Marco Fritzsche has been jointly funded by the Kennedy Trust and the Rosalind Franklin Institute to join the Kennedy Institute as the Principal Investigator of the Biophysical Immunology Laboratory (BPI). His lab is leading the development of a lattice...
CD2 corolla calls T cells to arms
A study led by Professor Mike Dustin’s group at the Kennedy Institute has visualised how key cells of the immune system lock onto cancerous or infected cells to destroy them. Read more here....
New insight into the causes of rheumatoid arthritis
Professor Chris Buckley and Dr Adam Croft at the University of Birmingham’s Rheumatology Research Group have identified the chemical messenger which instructs cells to destroy joints, leading to hope for new treatments. Read the full article here....
PhD student’s research review reveals potential to improve colon cancer treatments
Kennedy Trust’s PhD student Alina Janney at the Kennedy Institute for Rheumatology Research has published a paper in Nature reviewing the role of the microbiome in colorectal cancer. Read more...
Oxford researchers start new trial on the use of anti-TNF to treat COVID-19 in care homes
We are hopeful that anti-TNF therapy, first identified by Professor Sir Marc Feldmann and the Trust’s President Professor Sir Ravinder Maini, might prove to be an effective treatment for patients with COVID-19. Read the full article here....
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
Professors John Grainger and Tracy Hussell’s CIRCO study funded by the Kennedy Trust, which defines altered myeloid function in COVID-19 patients, has been published in Science Immunology. Read the full article here...